# Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS

> **NCT01515878** · PHASE4 · UNKNOWN · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 396 (estimated)

## Conditions studied

- Kidney Failure Chronic
- Cardiovascular Diseases

## Interventions

- **DEVICE:** Hemocontrol

## Key facts

- **NCT ID:** NCT01515878
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 396 (ESTIMATED)
- **Last updated:** 2012-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01515878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01515878, "Hemocontrol's Effectiveness on the Reduction of Cardiovascular Long-term EventS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01515878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*